Insights Center
ML Strategies Viewpoints
Search
Showing 9 - 16 of 492 results
ML Strategies Health Care Preview: House to Vote on Cadillac Tax
July 15, 2019|Blog
ML Strategies Health Care Preview: ACA Oral Arguments to Begin
July 8, 2019|Blog
MLS Weekly Preview: Medicare For All Gets a Hearing
April 26, 2019|Blog
MLS Weekly Preview: Congress Keeping its Focus on Drug Costs
April 8, 2019|Blog
ML Strategies Health Care Preview - Week of March 25, 2019
March 26, 2019
Device Modernization Series: In Vitro Clinical Tests
March 7, 2019|Blog
What to Expect at FDA Following Commissioner Gottlieb's Departure
March 6, 2019|Blog
News & Press Releases
To Pitch Pre-Cert to Congress, FDA Builds a Case First
September 26, 2019 | MedTechDive
MedTechDive reported that the U.S. Food and Drug Administration is not yet ready to go to Congress to seek new powers for its evolving precertification pilot for software, but it will need new authorities to determine how the experimental path fits into the current regulatory scheme. The article included commentary from Senior Director of ML Strategies Aaron Josephson and Mintz Associate Benjamin Zegarelli.
Former FDAer Defends FDA Decision to Withdraw Data Falsification Rule
August 20, 2019 | Inside Health Policy
An article published by Inside Health Policy quoted Aaron Josephson, Senior Director at ML Strategies, extensively in response to recent debate surrounding the U.S. Food and Drug Administration’s proposed rule “Reporting Information Regarding Falsification of Data,” which was previously withdrawn.
Events
Nov
8
2019